|
1
|
Sawada G, Niida A, Uchi R, Hirata H,
Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y,
et al: Genomic landscape of esophageal squamous cell carcinoma in a
Japanese population. Gastroenterology. 150:1171–1182. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mao Y, Li L, Liu J, Wang L and Zhou Y:
miR-495 inhibits esophageal squamous cell carcinoma progression by
targeting Akt1. Oncotarget. 7:51223–51236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang HY, Yao ZH, Tang H, Zhao Y, Jin SL,
Zhou WP, Yao SN, Yang SJ, Liu YY and Luo SX: A retrospective
clinical study of comparing paclitaxel plus S-1 versus paclitaxel
plus cisplatin as the first-line treatment for patients with
advanced esophageal squamous cell carcinoma. Oncotarget.
8:7540–7547. 2017.PubMed/NCBI
|
|
4
|
Hu D, Lin X, Chen Y, Chang Q, Chen G, Li
C, Zhang H, Cui Z, Liang B, Jiang W, et al: Preoperative
blood-routine markers and prognosis of esophageal squamous cell
carcinoma: The Fujian prospective investigation of cancer (FIESTA)
study. Oncotarget. 8:23841–23850. 2017.PubMed/NCBI
|
|
5
|
Kim R, Keam B, Kwon D, Ock CY, Kim M, Kim
TM, Kim HJ, Jeon YK, Park IK, Kang CH, et al: Programmed death
ligand-1 expression and its prognostic role in esophageal squamous
cell carcinoma. World J Gastroenterol. 22:8389–8397. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Li M, Gao F and Ge X: Serum
microRNA-15a level acts as a potential diagnostic and prognostic
biomarker for human esophageal squamous cell carcinoma. Cancer
Biomark. 18:11–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stein U, Smith J, Walther W and Arlt F:
MACC1 controls Met: What a difference an Sp1 site makes. Cell
Cycle. 8:2467–2469. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shirahata A, Shinmura K, Kitamura Y,
Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K,
Kigawa G, et al: MACC1 as a marker for advanced colorectal
carcinoma. Anticancer Res. 30:2689–2692. 2010.PubMed/NCBI
|
|
10
|
Ilm K, Fuchs S, Mudduluru G and Stein U:
MACC1 is post-transcriptionally regulated by miR-218 in colorectal
cancer. Oncotarget. 7:53443–53458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia J, Wang H, Huang H, Sun L, Dong S,
Huang N, Shi M, Bin J, Liao Y and Liao W: Elevated Orai1 and STIM1
expressions upregulate MACC1 expression to promote tumor cell
proliferation, metabolism, migration, and invasion in human gastric
cancer. Cancer Lett. 381:31–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z,
Li M, Li J and Song L: MACC1 as a prognostic biomarker for
early-stage and AFP-normal hepatocellular carcinoma. PLoS One.
8:e642352013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y,
Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, et al: Overexpression of
metastasis-associated in colon cancer 1 predicts a poor outcome of
hepatitis B virus-related hepatocellular carcinoma. World J
Gastroenterol. 18:2995–3003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan W, Xie X, Li L, Tang H, Ye X, Chen L,
Tang W, Gao J, Pan L, Zhang X, et al: Diagnostic and prognostic
value of serum MACC1 in breast cancer patients. Oncotarget.
7:84408–84415. 2016.PubMed/NCBI
|
|
15
|
Li H, Zhang H, Zhao S, Shi Y, Yao J, Zhang
Y, Guo H and Liu X: Overexpression of MACC1 and the association
with hepatocyte growth factor/c-Met in epithelial ovarian cancer.
Oncol Lett. 9:1989–1996. 2015.PubMed/NCBI
|
|
16
|
Sun L, Li G, Dai B, Tan W, Zhao H, Li X
and Wang A: Silence of MACC1 expression by RNA interference
inhibits proliferation, invasion and metastasis, and promotes
apoptosis in U251 human malignant glioma cells. Mol Med Rep.
12:3423–3431. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
DeVorkin L, Hattersley M, Kim P, Ries J,
Spowart J, Anglesio MS, Levi SM, Huntsman DG, Amaravadi RK, Winkler
JD, et al: Autophagy inhibition enhances sunitinib efficacy in
clear cell ovarian carcinoma. Mol Cancer Res. 15:250–258. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhan L, Zhang Y, Wang W, Song E, Fan Y, Li
J and Wei B: Autophagy as an emerging therapy target for ovarian
carcinoma. Oncotarget. 7:83476–83487. 2016.PubMed/NCBI
|
|
19
|
Ahn JS, Ann EJ, Kim MY, Yoon JH, Lee HJ,
Jo EH, Lee K, Lee JS and Park HS: Autophagy negatively regulates
tumor cell proliferation through phosphorylation dependent
degradation of the Notch1 intracellular domain. Oncotarget.
7:79047–79063. 2016.PubMed/NCBI
|
|
20
|
Guo W, Wang H, Yang Y, Guo S, Zhang W, Liu
Y, Yi X, Ma J, Zhao T, Liu L, et al: Down-regulated miR-23a
contributes to the metastasis of cutaneous melanoma by promoting
autophagy. Theranostics. 7:2231–2249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carchman EH, Matkowskyj KA, Meske L and
Lambert PF: Dysregulation of autophagy contributes to anal
carcinogenesis. PLoS One. 11:e01642732016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jia YL, Xu M, Dou CW, Liu ZK, Xue YM, Yao
BW, Ding LL, Tu KS, Zheng X and Liu QG: P300/CBP-associated factor
(PCAF) inhibits the growth of hepatocellular carcinoma by promoting
cell autophagy. Cell Death Dis. 7:e24002016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weh KM, Howell AB and Kresty LA:
Expression, modulation, and clinical correlates of the autophagy
protein Beclin-1 in esophageal adenocarcinoma. Mol Carcinog.
55:1876–1885. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee E, Wei Y, Zou Z, Tucker K, Rakheja D,
Levine B and Amatruda JF: Genetic inhibition of autophagy promotes
p53 loss-of-heterozygosity and tumorigenesis. Oncotarget.
7:67919–67933. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu C and Xie C: Radiation-induced
autophagy promotes esophageal squamous cell carcinoma cell survival
via the LKB1 pathway. Oncol Rep. 35:3559–3565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamada E, Okada S, Bastie CC, Vatish M,
Nakajima Y, Shibusawa R, Ozawa A, Pessin JE and Yamada M: Fyn
phosphorylates AMPK to inhibit AMPK activity and AMP-dependent
activation of autophagy. Oncotarget. 7:74612–74629. 2016.PubMed/NCBI
|
|
29
|
He Y, Mo Q, Luo B, Qiao Y, Xu R, Zuo Z,
Deng J, Nong X, Peng G, He W, et al: Induction of apoptosis and
autophagy via mitochondria- and PI3K/Akt/mTOR-mediated pathways by
E. adenophorum in hepatocytes of saanen goat. Oncotarget.
7:54537–54548. 2016. View Article : Google Scholar : PubMed/NCBI
|
